BRUNELLO, Nicoletta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.140
AS - Asia 8.616
EU - Europa 8.155
SA - Sud America 1.305
AF - Africa 191
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 9
Totale 35.455
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.846
SG - Singapore 3.092
GB - Regno Unito 2.109
CN - Cina 1.971
DE - Germania 1.700
IT - Italia 1.443
HK - Hong Kong 1.289
BR - Brasile 1.076
VN - Vietnam 867
SE - Svezia 711
RU - Federazione Russa 556
FI - Finlandia 393
KR - Corea 268
UA - Ucraina 249
FR - Francia 248
IN - India 223
TR - Turchia 210
BG - Bulgaria 177
CA - Canada 167
ID - Indonesia 97
BD - Bangladesh 96
IE - Irlanda 94
JP - Giappone 89
AR - Argentina 81
NL - Olanda 81
MX - Messico 80
PL - Polonia 76
ES - Italia 63
IQ - Iraq 62
ZA - Sudafrica 59
AE - Emirati Arabi Uniti 54
PK - Pakistan 46
CH - Svizzera 39
CZ - Repubblica Ceca 39
EC - Ecuador 39
AU - Australia 36
BE - Belgio 31
UZ - Uzbekistan 31
EG - Egitto 30
CO - Colombia 25
RO - Romania 25
PH - Filippine 23
LT - Lituania 22
SA - Arabia Saudita 21
VE - Venezuela 21
MA - Marocco 20
DZ - Algeria 19
JO - Giordania 19
TH - Thailandia 19
AT - Austria 18
CL - Cile 18
IL - Israele 16
KE - Kenya 16
PY - Paraguay 16
TW - Taiwan 16
IR - Iran 15
TN - Tunisia 14
AZ - Azerbaigian 13
MY - Malesia 13
DK - Danimarca 11
GR - Grecia 11
KZ - Kazakistan 11
PE - Perù 11
NP - Nepal 10
UY - Uruguay 10
ET - Etiopia 9
BO - Bolivia 8
DO - Repubblica Dominicana 8
SI - Slovenia 8
EE - Estonia 7
MD - Moldavia 7
OM - Oman 7
PR - Porto Rico 7
JM - Giamaica 6
LB - Libano 6
PT - Portogallo 6
RS - Serbia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
HU - Ungheria 5
PA - Panama 5
CR - Costa Rica 4
KG - Kirghizistan 4
NG - Nigeria 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
AM - Armenia 3
BB - Barbados 3
BH - Bahrain 3
BY - Bielorussia 3
EU - Europa 3
LY - Libia 3
NZ - Nuova Zelanda 3
QA - Qatar 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AF - Afghanistan, Repubblica islamica di 2
AN - Antille olandesi 2
AO - Angola 2
BZ - Belize 2
CI - Costa d'Avorio 2
Totale 35.410
Salva come PNG Salva come JPEG
Città #
Ashburn 1.698
Santa Clara 1.651
Fairfield 1.580
Singapore 1.424
Southend 1.265
Hong Kong 1.261
Chandler 1.038
Woodbridge 831
Houston 671
Wilmington 570
Hefei 514
San Jose 501
Cambridge 489
Seattle 461
Jacksonville 437
London 437
Nyköping 407
Los Angeles 385
Beijing 379
Chicago 362
Ann Arbor 330
Dearborn 326
Modena 307
The Dalles 298
Helsinki 288
Ho Chi Minh City 267
Seoul 245
Council Bluffs 230
Hanoi 223
San Diego 217
Princeton 187
New York 172
Sofia 170
Milan 138
Munich 138
Salt Lake City 138
Moscow 103
Buffalo 98
Dublin 92
São Paulo 82
Columbus 81
Eugene 77
Shanghai 73
Lauterbourg 72
Tampa 72
Elk Grove Village 70
Jakarta 69
Izmir 68
Tokyo 61
Rome 60
Dallas 57
Des Moines 57
Orem 55
Bologna 54
Da Nang 49
Falls Church 48
Frankfurt am Main 48
Warsaw 48
Istanbul 47
Atlanta 46
Fremont 45
Guangzhou 43
Haiphong 41
Redondo Beach 41
Redwood City 41
Toronto 41
Rio de Janeiro 40
Reggio Emilia 39
Denver 38
Lancaster 38
Norwalk 37
Phoenix 36
Montreal 34
Parma 34
Brooklyn 33
Chennai 33
Pittsburgh 33
Johannesburg 32
Brno 31
Mexico City 31
Manchester 30
San Francisco 30
Belo Horizonte 29
Sterling 29
Vancouver 28
Bremen 27
Miami 27
Poplar 27
Brasília 26
Turku 26
Baghdad 25
Tashkent 25
Hải Dương 24
Nanjing 24
Amsterdam 23
Boardman 23
Catania 23
San Mateo 23
Brussels 22
Paris 22
Totale 22.876
Salva come PNG Salva come JPEG
Nome #
Early neonatal inflammation affects adult pain reactivity and anxiety related traits in mice: genetic background counts 573
Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression 492
Chronic treatment with the selective NOP receptor antagonist [Nphe1,Arg14,Lys15]N/OFQ-NH2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats 492
Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders 472
N-acetyl-cysteine prevents toxic oxidative effects induced by IFN-α in human neurons. 449
Transcriptional profiles underlying vulnerability and resilience in rats exposed to an acute unavoidable stress 442
Chronic antidepressant treatments resulted in altered expression of genes involved in inflammation in the rat hypothalamus 439
Early postnatal chronic inflammation produces long-term changes in pain behavior and N-methyl-D-aspartate receptor subtype gene expression in the central nervous system of adult mice 423
Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats 420
Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in a rat model of depression 413
Disease-induced neuroinflammation and depression 399
Constitutive and LPS-regulated expression of interleukin-18 receptor beta variants in the mouse brain 392
Stress induces altered CRE/CREB pathway activity and BDNF expression in the hippocampus of glucocorticoid receptor-impaired mice 382
Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study 378
Behavioural and transcriptional effects of escitalopram in the chronic escape deficit model of depression 376
Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKK alpha and CaMKK beta mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor 375
Changes in the NMR Metabolic Profile of Live Human Neuron-Like SH-SY5Y Cells Exposed to Interferon-α2 369
Fluoxetine effects on molecular, cellular and behavioral endophenotypes of depression are driven by the living environment 363
Central effects of a local inflammation in three commonly used mouse strains with a different anxious phenotype 361
Successful treatment of HIV-1 infection increases the expression of a novel, short transcript for IL-18 receptor α chain 361
Behavioural and molecular effects of the combined treatment fluoxetine plus acetylsalicylic acid in a rat model of depression 358
LPS-induced histone H3 phospho(Ser10)-acetylation(Lys14) regulates neuronal and microglial neuroinflammatory response 357
Interferon alpha exposure increases the expression of the enzymes belonging to the kynurenine pathway in an in vitro model of human neurons: SH-SY5Y cells 343
Microarray analysis of the chronic escape deficit model of depression: Effects of escitalopram treatment in hippocampus 342
Regulation of ionotropic glutamate receptors in the rat brain in response to the atypical antipsychotic seroquel (quetiapine fumarate). . 337
Cognitive deficits and changes in gene expression of NMDA receptors after prenatal methylmercury exposure 332
Molecular changes associated with escitalopram response in a stress-based model of depression 324
Erratum to: Changes in the NMR Metabolic Profile of Live Human Neuron-Like SH-SY5Y Cells Exposed to Interferon-α2 (J Neuroimmune Pharmacol, 2015, DOI 10.1007/s11481-015-9641-x) 324
Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats. 322
Effects of acute stress on brain-derived neurotrophic factor in the hippocampus of transgenic mouse model of depression 321
Altered regulation of CREB by chronic antidepressant administration in the brain of transgenic mice with impaired glucocorticoid receptor function. 320
Neonatal persistent inflammation alters pain response and NMDA receptor expression in adult mice 318
P.1.04 Expression of histone variants H3.3 and H2a.z in the rat brain: Physiopathological and pharmacological implications 317
P.2.a.012 Co-administration of fluoxetine with acetylsalicylic acid, but not flurbiprofen or celecoxib, for one week shows an antidepressant-like effect 316
Interleukin 18 activates MAPKs and STAT3 but not NF-κB in hippocampal HT-22 cells 315
Fluoxetine treatment affects the inflammatory response and microglial function according to the quality of the living environment 314
Impaired stress-induced regulation of brain derived neurotrophic factor expression in hippocampus of glucocorticoid receptor impaired mice: Model of depression 312
Lymnaea stagnalis as model for translational neuroscience research: from pond to bench 309
Interferon-alpha exposure increases the expression of enzymes of the kynurenine pathway and induces apoptosis in a model of human neurons 305
Hypothalamic expression of inflammatory mediators in an animal model of binge eating 302
Mitochondrial energy metabolism of rat hippocampus after treatment with the antidepressants desipramine and fluoxetine 301
ADOLESCENCE AS A CRITICAL TIME-WINDOW FOR NEUROINFLAMMATION IN THE MOUSE: WHY SEX MATTERS 291
New combination therapies from animal to human 290
Molecular effects of subchronic andchronic treatment with escitalopram inthe rat central nervous system 289
Microarray analysis in hippocampus of rats treated with escitalopram in the chronic escape deficit model of depression 285
Restraint stress increases the expression of brain derived neurotrophic factor in the hippocampus of a mouse model of depression 283
Gene expression profile of the hippocampus of a behavioural model of depression 282
Environmental quality modulates the endocannabinoid system along the gut-brain axis in a mouse model of LPS-induced neuroinflammation 281
Combined effect of antidepressant and anti-inflammatory drugs in an animal model of depressio 281
Mapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain 280
Cloning of mouse Ca2+/calmodulin-dependent protein kinase kinase beta (CaMKKbeta) and characterization of CaMKKbeta and CaMKKalpha distribution in the adult mouse brain. 276
Regulation of CREB function in rat frontal cortex after combined treatment with Fluoxetine and Olanzapine 276
Combined fluoxetine and metformin treatment potentiates antidepressant efficacy increasing IGF2 expression in the dorsal hippocampus 275
Mood stabilizers: protecting the mood ... protecting the brain 274
The role of noradrenaline and selective noradrenaline reuptake inhibition in depression 273
Vortioxetine Prevents Lipopolysaccharide-Induced Memory Impairment Without Inhibiting the Initial Inflammatory Cascade 272
Modulation of neuroplasticity-related targets following stress-induced acute escape deficit 269
Environmental enrichment influences mouse hippocampal neuroinflammatory response 264
HTR1B as a risk profile maker in psychiatric disorders:a review through motivation and memory 261
Deciphering the central immunomodulatory effects of a vortioxetine pretreatment on the LPS-induced inflammatory cascade 257
Effect of reboxetine treatment on brain cAMP- and calcium/calmodulin-dependent protein kinases 256
Effect of desipramine and fluoxetine on energy metabolism of cerebral mitochondria 254
VORTIOXETINE ATTENUATES NEUROINFLAMMATION BY MODULATING THE NOD-LIKE RECEPTOR FAMILY PYRIN DOMAIN CONTAINING 3 INFLAMMASOME ACTIVATION IN MICROGLIA: IMPLICATIONS FOR COGNITIVE FUNCTION 253
Neither all anti-inflammatory drugs nor all doses are effective in accelerating the antidepressant-like effect of fluoxetine in an animal model of depression 252
Cyclic GMP inhibition of metabotropic glutamate receptor-induced phosphoinositide hydrolysis in mesencephalic neurons 248
Fluoxetine prevents Aβ1-42-induced toxicity via a paracrine signaling mediated by transforming-growth-factor-β1 248
Dysbindin, D3 receptors, and their genetic interaction differently regulate neuroplasticity genes in the mouse brain 239
Metabolic changes induced by interferon-α exposure in an in vitro model of human neurons 236
Carnosine Protects Macrophages against the Toxicity of Aβ1-42 Oligomers by Decreasing Oxidative Stress 227
Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas 222
Metabolic characterization of SH-SY5Y cells and effects of interferon-alpha exposure 218
Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment 217
Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment 215
cAMP-dependent binding proteins and endogenous phosphorylation after antidepressant treatment 215
Effect of idebenone on in vivo serotonin release and serotonergic receptors in young and aged rats 214
cAMP-dependent phosphorylation system after short and long-term administration of moclobemide 214
Interplay between inflammation and neural plasticity: Both immune activation and suppression impair LTP and BDNF expression 208
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? 206
Practical issues in clinical research of schizophrenia 204
cAMP binding proteins in the rat cerebral cortex after administration of selective 5-HT and NE reuptake blockers with antidepressant activity 200
Behavioural and neurochemical changes produced by lefetamine in two inbred strains of mice 191
P.304 Executive functioning and genetic variation in pediatric patients with cancer 189
Chiralità e farmaci antidepressivi 184
Identification and characterization of the kynurenine pathway in the pond snail Lymnaea stagnalis 182
cAMP-dependent phosphorylation of soluble and crude microtubule fractions of rat cerebral cortex after prolonged desmethylimipramine treatment 181
Second messenger-regulated protein kinases in the brain: Their functional role and the action of antidepressant drugs 180
Farmaci antidepressivi parte II: SNRI e farmaci multimodali 178
Serum metabolic signature of binge-like palatable food consumption in female rats by nuclear magnetic resonance spectroscopy 177
Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit NMDA receptor activity and prevent neurotoxicity in mesencephalic neuron in vitro 176
New insights into the biology of schizophrenia through the mechanism of action of clozapine. 175
Absence of [3H]SCH 23390 specific binding sites in anterior pituitary: Dissociation from effects on prolactin secretion 175
Behavioural and biochemical effects in C57BL/6J mice after a prolonged treatment with the δ‐opiate antagonist ICI 154129 173
Effect of reboxetine, a new antidepressant drug, on the central noradrenergic system: Behavioural and biochemical studies 166
BIOCHEMICAL AND MOLECULAR CHANGES IN RAT CEREBRAL CORTEX AFTER CHRONIC ANTIDEPRESSANT TREATMENT: ‘IN VITRO AND’‘IN VIVO’ STUDIES 165
Biochemical and behavioral changes in rats after prolonged treatment with desipramine: interaction with p-chlorophenylalanine 164
Age-related changes in 5HT uptake and [3H]imipramine binding sites in rat cerebral cortex 164
Escitalopram: meccanismo d’azione e profili clinico 161
Role of dopamine D3 receptors, dysbindin, and their functional interaction on the expression of key genes for neuroplasticity in the mouse brain 158
Age‐Related Changes in Rat Serotonergic and Adrenergic Systems and in Receptor Responsiveness to Subchronic Desipramine Treatment 157
Hippocampus-related effects of fluoxetine treatment under stressful vs enriched conditions 151
Totale 28.412
Salva come PNG Salva come JPEG
Categoria #
all - tutte 146.048
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.048
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021349 0 0 0 0 0 0 0 0 0 0 218 131
2021/20223.346 478 258 153 241 75 233 113 137 307 351 686 314
2022/20232.866 303 255 250 293 289 441 43 307 424 28 116 117
2023/20241.987 130 127 130 222 379 157 101 278 38 101 90 234
2024/20257.626 290 98 101 490 1.278 1.074 466 378 793 986 868 804
2025/202610.777 790 401 904 1.399 2.069 757 1.397 618 1.051 1.107 284 0
Totale 35.787